Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles.

导出 OA

翻译打印收藏纠错

第一作者： Takeshi,Sawada

第一单位： Shien-Lab, National Cancer Center Hospital, Tokyo, Japan.

作者： Takeshi,Sawada ^[1] ; Riet,Hilhorst ^[2] ; Savithri,Rangarajan ^[3] ; Masayuki,Yoshida ^[3] ; Yuko,Tanabe ^[4] ; Kenji,Tamura ^[5] ; Takayuki,Kinoshita ^[5] ; Tatsu,Shimoyama ^[4] ; Rinie,van Beuningen ^[2] ; Rob,Ruijtenbeek ^[3] ; Hitoshi,Tsuda ^[3] ; Fumiaki,Koizumi ^[6]

作者单位： Shien-Lab, National Cancer Center Hospital, Tokyo, Japan. ^[1] Division of Clinical Research Support, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. ^[2] PamGene International BV, 's-Hertogenbosch, The Netherlands. ^[3] Department of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan. ^[4] Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. ^[5] Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan. ^[6] Department of Basic Pathology, National Defense Medical College, Saitama, Japan. ^[7]

关键词 neoadjuvant chemotherapy peptide micro array triple negative breast cancer tumor infiltrating lymphocytes tyrosine kinase activity

DOI 10.18632/oncotarget.26026

PMID 30344939

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交